MaxCyte, Inc. Board of Directors

MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes next-generation cell therapies in the United States and internationally. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. The company also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. It licenses and sells its instruments and technology; and sells its consumables to developers of cell therapies, as well as to pharmaceutical and biotechnology companies for use in drug discovery and development, and bio-manufacturing. MaxCyte, Inc. was incorporated in 1998 and is headquartered in Rockville, Maryland.

Mr. Maher Masoud

Mr. Maher Masoud

President, CEO & Executive Director

Mr. Jack Horgan

Mr. Jack Horgan

Vice President of Corporate Development

Mr. Thomas Michael Ross

Mr. Thomas Michael Ross

Executive Vice President of Global Sales

Mr. Jay Gelfman

Mr. Jay Gelfman

Senior Vice President of Operations

Mr. David Sandoval

Mr. David Sandoval

Senior Vice President, General Counsel & Corporate Secretary

Ms. Jill Mayer

Ms. Jill Mayer

Senior Vice President of Human Resources

Mr. Ronald Evan Holtz CPA, Ph.D.

Mr. Ronald Evan Holtz CPA, Ph.D.

Executive Vice President of Administration

Leaving Board of Directors Review Your about to visit the following url Invalid URL

Loading...
Comments


Comment created.